# Thermo Fisher Scientific Moat Status: stale. Policy: company-analysis-1. Thermo Fisher demonstrates demand for differentiated instruments, multiyear customer commitments, historical pricing realization and repeated productivity gains. These establish current operating strengths, but the supplied passages do not establish durable switching barriers, protected technological superiority or a cost advantage over rivals. Pricing strength is demonstrated historically; its recent magnitude remains unclear. Insufficient moat evidence does not establish a weak competitive position. ## switching_costs Multiyear manufacturing, clinical research and warranty commitments establish continuing customer relationships. Integrated services and procurement standardization could increase switching friction, but actual replacement costs and customer lock-in are not demonstrated. Durability: Relevant service agreements typically last three to five years. This supports contractual visibility, without establishing renewal durability or barriers beyond the contract. Risks: Service quality failures, customer substitution and competition could weaken relationships. Cancellation rights and renewal outcomes are not supplied. Invalidation: The switching-cost hypothesis would be undermined by customers routinely transferring comparable projects or workflows without material disruption, or by sustained deterioration in renewals and customer allegiance. Competitors: Not established ## intangible_assets Specialized instruments and associated intellectual property support differentiated offerings. Instrument demand and historical pricing realization demonstrate commercial value, but protected superiority over competing technologies is unestablished. Durability: Demand strength appears in 2023 and the second quarter of 2026. Continued innovation is necessary; patent disclosures do not establish the duration or exclusivity of commercially decisive technologies. Risks: Changing technologies, competing price/performance improvements and intellectual-property challenges could erode differentiation. First-quarter 2026 instrument weakness demonstrates funding and demand sensitivity rather than proven competitive displacement. Invalidation: The differentiation hypothesis would be undermined by sustained customer migration to equivalent alternatives, repeated price concessions to maintain instrument demand, or loss of relevant technology rights followed by commercial deterioration. Competitors: Not established ## cost_advantage Repeated productivity improvements demonstrate an operating capability. Global sourcing, facility consolidation and manufacturing initiatives provide plausible cost mechanisms, but no comparative unit-cost advantage over rivals is established. Durability: Productivity contributions recur in 2023, 2025 and first-half 2026. Competitor replicability and the remaining opportunity for restructuring savings are unknown. Risks: Tariffs, unfavorable mix, lower volumes and recurring restructuring costs can absorb efficiency gains. Margin improvement alone does not prove a moat. Invalidation: The cost-advantage hypothesis would be undermined by evidence of equivalent competitor costs or persistent deterioration in comparable operating costs despite completed efficiency initiatives. Competitors: Not established - [https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774526000018/tmo-20251231.htm) · 2026-02-26 - [https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774526000144/tmo-20260627.htm) · 2026-07-31 - [https://www.sec.gov/Archives/edgar/data/97745/000119312526144585/d66426ddef14a.htm](https://www.sec.gov/Archives/edgar/data/97745/000119312526144585/d66426ddef14a.htm) · 2026-04-07 - [https://www.sec.gov/Archives/edgar/data/97745/000009774525000010/tmo-20241231.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774525000010/tmo-20241231.htm) · 2025-02-20 - [https://www.sec.gov/Archives/edgar/data/97745/000009774524000007/tmo-20231231.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774524000007/tmo-20231231.htm) · 2024-02-22 - [https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774526000092/tmo-20260328.htm) · 2026-05-01 - [https://www.sec.gov/Archives/edgar/data/97745/000009774526000138/q22026earnings8kex99_1.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774526000138/q22026earnings8kex99_1.htm) · 2026-07-23 - [https://www.sec.gov/Archives/edgar/data/97745/000009774526000086/q12026earnings8kex99_1.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774526000086/q12026earnings8kex99_1.htm) · 2026-04-23 - [https://www.sec.gov/Archives/edgar/data/97745/000009774526000012/q42025earnings8kex99_1.htm](https://www.sec.gov/Archives/edgar/data/97745/000009774526000012/q42025earnings8kex99_1.htm) · 2026-01-29 [JSON](https://beanvest.com/stock/tmo/moat.json)